Literature DB >> 32047901

Lower Serum Magnesium Concentrations are associated With Specific Heavy Drinking Markers, Pro-Inflammatory Response and Early-Stage Alcohol-associated Liver Injury§.

Vatsalya Vatsalya1,2,3,4, Khushboo S Gala1, Maithili Mishra5, Melanie L Schwandt6, John Umhau6, Matthew C Cave1,2,3,4,7, Dipendra Parajuli1,2, Vijay A Ramchandani6, Craig J McClain1,2,3,4,7.   

Abstract

AIM: Chronic heavy alcohol intake frequently causes liver inflammation/injury, and altered mineral metabolism may be involved in this liver pathology. In this study, we evaluated the association of heavy drinking, changes in serum magnesium levels and biochemical evidence of liver injury in alcohol-use-disorder (AUD) patients who had no clinical signs or symptoms of liver injury. We also aimed to identify any sex-based differences in patients with mild or no biochemical evidence of liver injury induced by heavy drinking.
METHODS: 114 heavy drinking alcohol-dependent (AD) female and male patients aged 21-65 years without clinical manifestations of liver injury, who were admitted to an alcohol treatment program, were grouped by alanine aminotransaminase (ALT) levels: ≤ 40 IU/L, as no liver injury (GR.1), and ALT>40 IU/L as mild liver injury (GR.2). Patients were actively drinking until the day of admission. Comprehensive metabolic biochemistry results, fatty acid panel, serum magnesium and drinking history data were collected at admission; and study-specific measures were evaluated.
RESULTS: In all AD patients, lower magnesium was significantly associated with the heavy drinking marker and heavy drinking days past 90 days (HDD90). A lower serum magnesium concentration was observed in AD patients with mild liver injury. Females of both groups had mean levels of magnesium in the deficient range. A clinically significant drop in magnesium levels was observed only in the GR.2 (mild liver injury) male AD patients. Females showed a significant association between low magnesium levels and the ω6:ω3 polyunsaturated fatty acids (PUFAs) ratio.
CONCLUSIONS: Specific heavy drinking markers showed an association with lower magnesium levels. Low serum magnesium levels are common in subjects with AUD and appear to be associated with the onset of liver injury. Published by Oxford University Press 2020.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32047901      PMCID: PMC7082490          DOI: 10.1093/alcalc/agaa001

Source DB:  PubMed          Journal:  Alcohol Alcohol        ISSN: 0735-0414            Impact factor:   2.826


  33 in total

1.  Chronic EtOH administration alters liver Mg2+ homeostasis.

Authors:  Andrew Young; Christie Cefaratti; Andrea Romani
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2003-01       Impact factor: 4.052

2.  The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases.

Authors:  Koji Fukushima; Yoshiyuki Ueno; Naoki Kawagishi; Yasuteru Kondo; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Yuta Wakui; Naoko Saito; Susumu Satomi; Tooru Shimosegawa
Journal:  Tohoku J Exp Med       Date:  2011-07       Impact factor: 1.848

Review 3.  Magnesium metabolism in health and disease.

Authors:  Carlos G Musso
Journal:  Int Urol Nephrol       Date:  2009-03-10       Impact factor: 2.370

Review 4.  Magnesium deficiency in alcoholism.

Authors:  E B Flink
Journal:  Alcohol Clin Exp Res       Date:  1986-12       Impact factor: 3.455

Review 5.  The importance of the ratio of omega-6/omega-3 essential fatty acids.

Authors:  A P Simopoulos
Journal:  Biomed Pharmacother       Date:  2002-10       Impact factor: 6.529

6.  Assessing drinking outcomes in alcohol treatment efficacy studies: selecting a yardstick of success.

Authors:  Linda Carter Sobell; Mark B Sobell; Gerard J Connors; Sangeeta Agrawal
Journal:  Alcohol Clin Exp Res       Date:  2003-10       Impact factor: 3.455

7.  Acute effects of alcohol ingestion on the human serum concentrations of calcium and magnesium.

Authors:  A Petroianu; J Barquete; E G Plentz; C Bastos; D J Maia
Journal:  J Int Med Res       Date:  1991 Sep-Oct       Impact factor: 1.671

8.  The effect of a single dose of morphine and ethanol on magnesium level in blood serum and tissues in mice.

Authors:  A Papierkowski; K Pasternak
Journal:  Magnes Res       Date:  1998-06       Impact factor: 1.115

9.  Magnesium intake and mortality due to liver diseases: Results from the Third National Health and Nutrition Examination Survey Cohort.

Authors:  Lijun Wu; Xiangzhu Zhu; Lei Fan; Edmond K Kabagambe; Yiqing Song; Menghua Tao; Xiaosong Zhong; Lifang Hou; Martha J Shrubsole; Jie Liu; Qi Dai
Journal:  Sci Rep       Date:  2017-12-20       Impact factor: 4.379

10.  Magnesium treatment in alcoholics: a randomized clinical trial.

Authors:  Kari Poikolainen; Hannu Alho
Journal:  Subst Abuse Treat Prev Policy       Date:  2008-01-25
View more
  5 in total

1.  Theragnostic Efficacy of K18 Response in Alcohol Use Disorder with Clinically Significant Fibrosis Using Gut-Liver Axis.

Authors:  Manasa Sagaram; Ranganathan Parthasarathy; Sally L Condon; Charles F Closson; Maiying Kong; Melanie L Schwandt; Loretta L Jophlin; Wenke Feng; Ashutosh J Barve; Vatsalya Vatsalya
Journal:  Int J Mol Sci       Date:  2022-05-23       Impact factor: 6.208

2.  The Activities of Zinc and Magnesium Among Alcohol Dependence Syndrome Patients: A Case-Control Study From a Tertiary Care Teaching Hospital in South India.

Authors:  Pratyusha Pavuluri; Sharanya Jangili; Likhitha Ryakam; Sabitha Vadakedath; Sarat Chandan Tummalacharla; Deepthi Kondu; Venkataramana Kandi
Journal:  Cureus       Date:  2022-04-26

Review 3.  Emerging Noninvasive Biomarkers, and Medical Management Strategies for Alcoholic Hepatitis: Present Understanding and Scope.

Authors:  Khushboo S Gala; Vatsalya Vatsalya
Journal:  Cells       Date:  2020-02-25       Impact factor: 6.600

4.  Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients.

Authors:  Evan J Winrich; Khushboo S Gala; Abhas Rajhans; Christian D Rios-Perez; Amor J Royer; Zarlakhta Zamani; Ranganathan Parthasarathy; Luis S Marsano-Obando; Ashutosh J Barve; Melanie L Schwandt; Vatsalya Vatsalya
Journal:  Int J Mol Sci       Date:  2022-09-26       Impact factor: 6.208

Review 5.  Inflammatory Biomarkers in Addictive Disorders.

Authors:  Alvaro Morcuende; Francisco Navarrete; Elena Nieto; Jorge Manzanares; Teresa Femenía
Journal:  Biomolecules       Date:  2021-12-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.